NFKB1 and COVID-19: TNF-α signaling via NF-kB is a target as it is associated with the inflammation-triggered CVDs [59,60], cancer cell migration and invasion [61,62,63], the pathogenesis of CKDs [64,65,66], and severity of COVID-19 [67,68,69].